Knoll A - Search Results

1

The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease.

Weidemann F, Breunig F, Beer M, Sandstede J, Störk S, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM. Weidemann F, et al. Among authors: knoll a. Eur Heart J. 2005 Jun;26(12):1221-7. doi: 10.1093/eurheartj/ehi143. Epub 2005 Feb 23. Eur Heart J. 2005. PMID: 15728649

2

Morbus Fabry of the heart. Why should cardiologists care?

Strotmann J, Weidemann F, Breunig F, Knoll A, Wanner C, Ertl G. Strotmann J, et al. Among authors: knoll a. Z Kardiol. 2005 Sep;94(9):557-63. doi: 10.1007/s00392-005-0284-4. Z Kardiol. 2005. PMID: 16142514 Review.

3

Clinical benefit of enzyme replacement therapy in Fabry disease.

Breunig F, Weidemann F, Strotmann J, Knoll A, Wanner C. Breunig F, et al. Among authors: knoll a. Kidney Int. 2006 Apr;69(7):1216-21. doi: 10.1038/sj.ki.5000208. Kidney Int. 2006. PMID: 16609685 Free article. Clinical Trial.

4

Enzyme replacement therapy in Fabry disease: clinical implications.

Breunig F, Knoll A, Wanner C. Breunig F, et al. Among authors: knoll a. Curr Opin Nephrol Hypertens. 2003 Sep;12(5):491-5. doi: 10.1097/00041552-200309000-00002. Curr Opin Nephrol Hypertens. 2003. PMID: 12920395 Review.

5

Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study.

Weidemann F, Breunig F, Beer M, Sandstede J, Turschner O, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM. Weidemann F, et al. Among authors: knoll a. Circulation. 2003 Sep 16;108(11):1299-301. doi: 10.1161/01.CIR.0000091253.71282.04. Epub 2003 Sep 2. Circulation. 2003. PMID: 12952834 Clinical Trial.

6

Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy.

Beer M, Weidemann F, Breunig F, Knoll A, Koeppe S, Machann W, Hahn D, Wanner C, Strotmann J, Sandstede J. Beer M, et al. Among authors: knoll a. Am J Cardiol. 2006 May 15;97(10):1515-8. doi: 10.1016/j.amjcard.2005.11.087. Epub 2006 Mar 29. Am J Cardiol. 2006. PMID: 16679096

7

Umbilical angiectases as the sole clinical sign of Fabry disease in a 9-year-old boy.

Eggert AO, Wössner R, Knoll A, Hamm H, Wanner C, Breunig FB. Eggert AO, et al. Among authors: knoll a. Eur J Pediatr. 2006 Mar;165(3):205-6. doi: 10.1007/s00431-005-0029-4. Epub 2005 Nov 3. Eur J Pediatr. 2006. PMID: 16267681 No abstract available.

8

Nuclear protein p8 is associated with glucose-induced pancreatic beta-cell growth.

Päth G, Opel A, Knoll A, Seufert J. Päth G, et al. Among authors: knoll a. Diabetes. 2004 Feb;53 Suppl 1:S82-5. doi: 10.2337/diabetes.53.2007.s82. Diabetes. 2004. PMID: 14749270

9

Glucose-dependent expansion of pancreatic beta-cells by the protein p8 in vitro and in vivo.

Päth G, Opel A, Gehlen M, Rothhammer V, Niu X, Limbert C, Romfeld L, Hügl S, Knoll A, Brendel MD, Bretzel RG, Seufert J. Päth G, et al. Among authors: knoll a. Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1168-76. doi: 10.1152/ajpendo.00436.2005. Epub 2006 Jul 5. Am J Physiol Endocrinol Metab. 2006. PMID: 16822955 Free article.

10

Modeling Grid Cell Distortions with a Grid Cell Calibration Mechanism.

Strauß D, Bing Z, Zhuang G, Huang K, Knoll A. Strauß D, et al. Among authors: knoll a. Cyborg Bionic Syst. 2024 Sep 12;5:0140. doi: 10.34133/cbsystems.0140. eCollection 2024. Cyborg Bionic Syst. 2024. PMID: 39678069 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

602 results

Search Page

Filters